Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jett Crowdis

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Bioinformatics (Oxford, England)|June 6, 2020
CoMut: visualizing integrated molecular information with comutation plotsJett Crowdis, Meng Xiao He, Brendan Reardon, et al.
The Journal of Clinical Investigation|May 17, 2024
Somatic structural variants drive distinct modes of oncogenesis in melanomaJake R Conway, Riaz Gillani, Jett Crowdis, et al.
Nature|September 23, 2021
Biologically informed deep neural network for prostate cancer discoveryHaitham A Elmarakeby, Justin Hwang, Rand Arafeh, et al.
Oncogene|October 27, 2021
Clonal populations of a human TNBC model display significant functional heterogeneity and divergent growth dynamics in distinct contextsHendrik J Kuiken, Sabin Dhakal, Laura M Selfors, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Analysis of evolutionary dynamics and clonal architecture in prostate cancerJake R Conway, Alok K Tewari, Sabrina Y Camp, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Rare germline structural variants increase risk for pediatric solid tumorsRiaz Gillani, Ryan L Collins, Jett Crowdis, et al.
Science (New York, N.Y.)|January 2, 2025
Rare germline structural variants increase risk for pediatric solid tumorsRiaz Gillani, Ryan L Collins, Jett Crowdis, et al.
JCO Precision Oncology|September 8, 2022
Mutational Footprint of Platinum Chemotherapy in a Secondary Thyroid CancerJulia Schiantarelli, Theodora Pappa, Jake Conway, et al.
NPJ Precision Oncology|April 28, 2026
Multi-modal circulating cell-free DNA profiling to predict response to docetaxel in metastatic castration-resistant prostate cancerDavid D Chen, Anat Zimmer, David D Yang, et al.
Cell Reports|September 8, 2021
Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancerAlok K Tewari, Alexander T M Cheung, Jett Crowdis, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Bioinformatics (Oxford, England)|June 6, 2020
CoMut: visualizing integrated molecular information with comutation plotsJett Crowdis, Meng Xiao He, Brendan Reardon, et al.
The Journal of Clinical Investigation|May 17, 2024
Somatic structural variants drive distinct modes of oncogenesis in melanomaJake R Conway, Riaz Gillani, Jett Crowdis, et al.
Nature|September 23, 2021
Biologically informed deep neural network for prostate cancer discoveryHaitham A Elmarakeby, Justin Hwang, Rand Arafeh, et al.
Oncogene|October 27, 2021
Clonal populations of a human TNBC model display significant functional heterogeneity and divergent growth dynamics in distinct contextsHendrik J Kuiken, Sabin Dhakal, Laura M Selfors, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Analysis of evolutionary dynamics and clonal architecture in prostate cancerJake R Conway, Alok K Tewari, Sabrina Y Camp, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Rare germline structural variants increase risk for pediatric solid tumorsRiaz Gillani, Ryan L Collins, Jett Crowdis, et al.
Science (New York, N.Y.)|January 2, 2025
Rare germline structural variants increase risk for pediatric solid tumorsRiaz Gillani, Ryan L Collins, Jett Crowdis, et al.
JCO Precision Oncology|September 8, 2022
Mutational Footprint of Platinum Chemotherapy in a Secondary Thyroid CancerJulia Schiantarelli, Theodora Pappa, Jake Conway, et al.
NPJ Precision Oncology|April 28, 2026
Multi-modal circulating cell-free DNA profiling to predict response to docetaxel in metastatic castration-resistant prostate cancerDavid D Chen, Anat Zimmer, David D Yang, et al.
Cell Reports|September 8, 2021
Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancerAlok K Tewari, Alexander T M Cheung, Jett Crowdis, et al.
Pageof 2